Peptide R (TFA) is a high-affinity, CXCR4-selective antagonist that rapidly reprograms tumor stroma, enhancing penetration of ADCs and immunotherapies. Stabilized as a TFA salt for reproducible in-vivo and in-vitro studies, it is ideal for glioblastoma and solid-tumor research.
Usually ships within 24 hours.